Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|January 26, 2017
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPIJulio Delgado, Michael Doubek, Tycho Baumann, et al.
Blood|October 18, 2002
Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemiaStefano Molica, Angelo Vacca, Domenico Ribatti, et al.
Cancer|December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemiaStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Leukemia Research|November 4, 2011
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)Stefano Molica, Giovanna Digiesi, Anna Antenucci, et al.
European Journal of Haematology|April 13, 2026
Bridging Trials and Real Life in Fixed-Duration BTKi-Venetoclax for CLL: A Delphi-Enhanced Synthesis Incorporating Artificial Intelligence (AI) BenchmarksStefano Molica, Mariano Lucignano, Maria Rosaria Villa, et al.
Hematological Oncology|January 21, 2023
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experienceLuca Laurenti, Lydia Scarfò, Anna Maria Frustaci, et al.
European Journal of Haematology|May 23, 2009
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Rosanna Mirabelli, et al.
Haematologica|November 5, 2002
Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myelomaFortunato Morabito, Massimo Martino, Caterina Stelitano, et al.
Pageof 16